Fundraising FoxBiotech Startups
11,136 companies tagged Biotech, with their investors and founders.
0 investors
0 investors
Renovo Concepts develops Mechanical Tissue Resuscitation (MTR), a therapy that applies controlled sub-atmospheric pressure to remove excess fluid from damaged brain, heart, and spinal tissue in order to reduce secondary injury. Its first clinical indication is traumatic brain injury, and the company is conducting first-in-human clinical trials.
0 investors
Replicate Bioscience develops self-replicating RNA (srRNA) vector therapeutics that use cells' own machinery to produce sustained protein expression, aiming for durable therapeutic effects. Its pipeline targets several therapeutic areas including infectious disease, oncology, and autoimmune disorders.
0 investors
Repligen develops bioprocessing technologies—including process intensification, tangential flow filtration, chromatography, process analytics, and single-use fluid management—for upstream and downstream biopharmaceutical workflows. Its solutions serve biopharma and CDMO teams developing modalities such as mAbs, ADCs, mRNA, and cell and gene therapies, from process development through GMP manufacturing.
0 investors
Reprise Biomedical develops and commercializes biologic medical devices using a proprietary perfusion decellularization process for surgical applications. The company serves physicians and healthcare providers delivering medical devices for a range of surgical procedures.
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
Retham Technologies develops diagnostic assays for heparin-induced thrombocytopenia (HIT) and related blood disorders. The company serves clinical laboratories and healthcare systems with in vitro diagnostic tests.
0 investors
RetinalGenix develops a high-resolution retinal imaging device for mass screening that does not require pupil dilation, aimed at early detection of ocular, neuro-degenerative, cardiovascular, vascular, metabolic, and diabetic conditions. The technology targets screening for both eye diseases and systemic diseases.
0 investors
Retrieve Medical develops AI-powered documentation and administrative tools for healthcare providers to reduce documentation burden and improve clinical efficiency. The company combines clinical expertise with machine learning to help providers capture comprehensive patient care records.
0 investors
Retrotope is a clinical-stage biopharmaceutical company developing proprietary therapeutics that down-regulate lipid peroxidation to treat degenerative diseases, including neurodegenerative conditions such as INAD, Friedreich's ataxia, ALS, and PSP, as well as dry age-related macular degeneration. Its drug candidates are based on stabilized polyunsaturated fatty acids from its proprietary drug discovery platform.
0 investors
Revalesio is a clinical-stage pharmaceutical company developing mitochondrial-targeted therapies for stroke and neurodegenerative diseases. The company focuses on treatments that restore mitochondrial health to improve cellular recovery and protect neurons in acute brain injury and aging-related neurological decline.
0 investors
0 investors
RevBio Sciences develops Gemini, an intravenously administered formulation of phosphorylated hexaacyl disaccharide (PHAD) designed to reduce inflammation-related damage by reprogramming the innate immune system to respond to stress such as trauma and infection in an attenuated way. The company works in therapeutics and immunology.
0 investors
Reven is a biotech company developing RJX technology to address treatment needs for patients with limited therapeutic options. The company has conducted over a decade of research, including FDA-approved clinical studies and is currently investigating the technology's applications across multiple treatment modalities.
0 investors
0 investors